PHIO PHARMACEUTICALS
Phio Pharmaceuticals is a biotechnology company developing immuno-oncology therapeutics based on its self-delivering RNAi (sd-rxRNA) therapeutic platform. The company's discovery and research efforts are focused on developing sd-rxRNA therapeutic compounds to be used in the context of adoptive cell transfer by targeting checkpoints or other gene targets or to be used in immunotherapy following intratumoral injection. It aims to maximize the power of ita sd-rxRNA therapeutic compounds by weaponizing therapeutic immune effector cells to attack cancer and to make tumors more susceptible to such attacks, and ultimately provide patients battling cancers with a new treatment option that goes beyond current treatment modalities.
PHIO PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical
Founded:
2011-01-01
Address:
Worcester, Massachusetts, United States
Country:
United States
Website Url:
http://www.phiopharma.com
Total Employee:
11+
Status:
Active
Contact:
5083665877
Email Addresses:
[email protected]
Total Funding:
87.04 M USD
Technology used in webpage:
IPhone / Mobile Compatible Domain Not Resolving IPv6 Nginx 1.14 Akamai Hosted Verizon Verizon FIOS
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Praxis Precision Medicines
Praxis Precision Medicines offers drug development services.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-10-12 | MirImmune | MirImmune acquired by Phio Pharmaceuticals | N/A |
| 2011-03-31 | Apthera | Apthera acquired by Phio Pharmaceuticals | N/A |
Investors List
OPKO Health
OPKO Health investment in Post-IPO Equity - Phio Pharmaceuticals
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - Phio Pharmaceuticals
Official Site Inspections
http://www.phiopharma.com Semrush global rank: 4.96 M Semrush visits lastest month: 1.71 K
- Host name: 151.101.194.159
- IP address: 151.101.194.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
